Endothelial chimerism after ABO-Incompatible kidney transplantation

Transplantation

Volumn 93, Issue 7, 2012, Pages 709-716

  Tanabe, Tatsu ^a,b   Ishida, Hideki ^a   Horita, Shigeru ^a   Honda, Kazuho ^a   Yamaguchi, Yutaka ^c   Nonomura, Katsuya ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Yamaguchi Pathological Research Institute   (Japan)

Author keywords

ABO incompatibility; Chimerism; Chronic allograft rejection; Endothelial cells; Kidney transplantation

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; CALCINEURIN INHIBITOR;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; CHIMERA; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; DISEASE COURSE; ENDOTHELIAL CHIMERISM; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT FAILURE; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; SURVIVAL RATE; Y CHROMOSOME;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; BIOPSY; BLOOD GROUP INCOMPATIBILITY; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; ENDOTHELIAL CELLS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRANSPLANTATION CHIMERA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859258615     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31824612b5     Document Type: Article

References (25)

1. Al-Lamki RS, Bradley JR, Pober JS. Endothelial cells in allograft rejection. Transplantation 2008; 86: 1340
2. Tanaka Y, Haga H, Egawa H, et al. Intragraft expression of recipienttype ABO blood group antigens: Long-term follow-up and histological features after liver transplantation. Liver Transpl 2005; 11: 547
3. Murata H, Ratajczak P, Meignin V, et al. Endothelial cell chimerism associated with graft rejection after human lung transplantation. Transplantation 2008; 85: 150
4. Koestner S, Kappeler A, Schaffner T, et al. ABO histo-blood group antigen expression on the graft endothelium long term after ABOcompatible, non-identical heart transplantation. Xenotransplantation 2006; 13: 166
5. Lagaaij E, Cramer-Knijnenburg G, van Kemenade F, et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33
6. van Poelgeest EP, Baelde HJ, Lagaaij EL, et al. Endothelial cell chimerism occurs more often and earlier in female than in male recipients of kidney transplants. Kidney Int 2005; 68: 847
7. Bai HW, Shi BY, Qian YY, et al. Does endothelial chimerism correlate with renal allograft rejection? Transplant Proc 2006; 38: 3430
8. Ferlicot S, Vernochet A, Romana S, et al. Microchimerism in renal allografts: Clinicopathological associations according to the type of chimeric cells. Histopathology 2010; 56: 188
9. Medawar P. Transplantation of tissues and organs: Introduction. Br Med Bull 1965; 21: 97
10. Koopmans M, Kremer Hovinga IC, et al. Chimerism in kidneys, livers and hearts of normal women: Implications for transplantation studies. Am J Transplant 2005; 5: 1495
11. Koopmans M, Kremer Hovinga IC, Baelde HJ, et al. Endothelial chimerism in transplantation: Looking for needles in a haystack. Transplantation 2006; 82: S25
12. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 2007; 84: S4
13. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-Single center analysis. Am J Transplant 2007; 7: 825
14. Toki D, Ishida H, Horita S, et al. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int 2009; 22: 447
15. Breimer ME, Mölne J, Nordén G, et al. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006; 82: 479
16. Yoshida A, Davè V, Hamilton HB. Imbalance of blood group A subtypes and the existence of superactive B gene in Japanese in Hiroshima and Nagasaki. Am J Hum Genet 1988; 43: 422
17. Tanabe T, Ishida H, Horita S, et al. Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation. Transpl Immunol 2011; 25: 1
18. Kobayashi A, Takahashi T, Horita S, et al. Activation of the transcription factor c-Jun in acute cellular and antibody-mediated rejection after kidney transplantation. Hum Pathol 2010; 41: 1682
19. Rienstra H, Boersema M, Onuta G, et al. Donor and recipient origin of mesenchymal and endothelial cells in chronic renal allograft remodeling. Am J Transplant 2009; 9: 463
20. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481
21. Ito T, Suzuki A, Imai E, et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 2001; 12: 2625
22. Cornacchia F, Fornoni A, Plati AR, et al. Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 2001; 108: 1649
23. Ladhoff J, Fleischer B, Hara Y, et al. Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res 2010; 88: 121
24. Koestner S, Kappeler A, Schaffner T, et al. Histo-blood group type change of the graft from B toOafter ABO mismatched heart transplantation. Lancet 2004; 363: 1523
25. Soles K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.